| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/01/2007 | CN101007841A Method for separating and purifying ACE inhibition peptide from rice draff and active peptide obtained therefor |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007172A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 08/01/2007 | CN101007166A Use of derivatives of erythropoietin carbamylated in preparation of medicine |
| 08/01/2007 | CN101007165A A compound preparation for treating respiratory tract infection and its preparation method |
| 08/01/2007 | CN101007164A Compound ofloxacin injection and its preparation method |
| 08/01/2007 | CN101007163A Healing agent for intestinal mucosal injury and its preparation method |
| 08/01/2007 | CN101007027A Application method of neural regulation protein in the treatment of cardiovascular diseases and its composition |
| 08/01/2007 | CN101007024A Spirulina containing active peptide, protease and protein kinase, and its processing method and application |
| 08/01/2007 | CN101007020A Composition of a cartilage protein and its application in medical treatment and health protection |
| 07/31/2007 | US7251525 Treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions as antiarrhythmia |
| 07/31/2007 | US7250529 Or salt thereof, by oxidation of 1-acetyl-3-hydroxyadamantane using permanganate oxidant in a liquid phase; use as a commercial chemical intermediate |
| 07/31/2007 | US7250503 Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics |
| 07/31/2007 | US7250500 Nematode PAN and ZP receptor-like sequences |
| 07/31/2007 | US7250498 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
| 07/31/2007 | US7250495 PRO20044 polypeptides |
| 07/31/2007 | US7250493 FC fusion proteins of human erythropoietin with increased biological activities |
| 07/31/2007 | US7250491 Hemolytic active proteins and genes encoding the same |
| 07/31/2007 | US7250489 Detecting nut allergy |
| 07/31/2007 | US7250488 Transcriptional activation inhibitory protein |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250405 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250401 Therapeutic compositions |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250398 Useful as animal feed additives, particularly further containing phytase, xylanase, galactanase, and/or beta-glucanase |
| 07/31/2007 | US7250397 Antiarrhythmic peptides |
| 07/31/2007 | US7250395 Antagonist peptides to VEGF receptor Flt-1 |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250278 α-keto acid reductase, method for producing the same, and method for producing optically active α-hydroxy acids using the same |
| 07/31/2007 | US7250276 Used to study cellular processes such as immune regulation, cell proliferation, cell death, and inflammatory responses |
| 07/31/2007 | US7250273 Human peroxisome proliferator activated receptor γ: compositions and methods |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | US7250264 Administering to host a therapeutically effective amount of an agent which prevents the interaction of mucosal addressin cell adhesion molecule-1 with a ligand therefor |
| 07/31/2007 | US7250256 Its expression products can be used to provide reagents and methods for detecting neoplasia |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250177 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 07/31/2007 | US7250172 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 07/31/2007 | US7250169 Anti-tumor activity of Ea-4-peptide of pro-IGF-1 |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250163 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | US7250154 Radio-opaque polymeric biomaterials |
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2331936C Proteins with changed epitopes and methods for the production thereof |
| 07/31/2007 | CA2284863C Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 07/31/2007 | CA2240705C Cyclosporin-containing soft capsule preparations |
| 07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/31/2007 | CA2077763C Use of leukaemia inhibitory factor for regulating neuron development and maintenance |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007084895A2 Peptide-based regulation of gap junctions |
| 07/26/2007 | WO2007084765A2 Injectable combination therapy for eye disorders |
| 07/26/2007 | WO2007084743A2 Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 07/26/2007 | WO2007084737A2 Intraventricular enzyme delivery for lysosomal storage diseases |
| 07/26/2007 | WO2007084670A2 Specific therapy using integrin ligands for treating cancer |
| 07/26/2007 | WO2007084651A2 Methods and kits to treat chronic inflammatory immune diseases |
| 07/26/2007 | WO2007084642A2 Coated catheters |
| 07/26/2007 | WO2007084559A2 Methods to treat disease states by influencing the signaling of ox40-receptors and high throughput screening methods for identifying substances therefor |
| 07/26/2007 | WO2007084544A2 Methods of treating or preventing tissue damage caused by increased blood flow |
| 07/26/2007 | WO2007084507A2 [ψ[CH2NH]PG4] GLYCOPEPTIDE ANTIBIOTIC ANALOGS |
| 07/26/2007 | WO2007084460A2 Pharmaceutical compositions with enhanced stability |
| 07/26/2007 | WO2007084441A2 Novel fsh glycosylation variant d3n |
| 07/26/2007 | WO2007084388A2 Nogo-b receptor |
| 07/26/2007 | WO2007084158A2 Novel use |
| 07/26/2007 | WO2007084136A2 Treatment of acute respiratory distress syndrome |
| 07/26/2007 | WO2007084059A1 A food composition comprising amino acids |
| 07/26/2007 | WO2007084001A2 Means and methods for modulating stem cell mobilization |
| 07/26/2007 | WO2007083806A1 HEPATITIS C VIRUS 2a-DERIVED HLA-A2-RESTRICTED ANTIGEN PEPTIDE |
| 07/26/2007 | WO2007083763A1 Method for production of emulsion preparation comprising physiologically active peptide, and kit for production of the preparation |
| 07/26/2007 | WO2007083603A1 Therapeutic agent |
| 07/26/2007 | WO2007083425A1 Pharmaceutical composition, food or drink, or feed for intestinal disease |
| 07/26/2007 | WO2007083402A1 Nutritional supplement for promotion of hair growth and/or hair restoration |
| 07/26/2007 | WO2007083323A2 Modified release oral dosage form comprising desmopressin |
| 07/26/2007 | WO2007083246A2 Vegf variants |
| 07/26/2007 | WO2007083146A2 The treatment of cognitive and psychotic disorders |
| 07/26/2007 | WO2007083133A1 Treatment of nerve damage by modulation of cellular alpha 9 integrin levels |
| 07/26/2007 | WO2007083101A2 Use in an alternative treatment of cancer |
| 07/26/2007 | WO2007082980A1 Compositions and methods for treating inflammatory, immune disorders with cortistatin |
| 07/26/2007 | WO2007082973A1 Use of a polypeptide that comprises the c-terminal domain of the heavy chain of tetanus toxin in the treatment of parkinsonism |
| 07/26/2007 | WO2007082909A2 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 07/26/2007 | WO2007082742A1 Isolated organ perfusion combination therapy of cancer |
| 07/26/2007 | WO2007082712A1 Long-acting colloidal formulation of insulin and preparation thereof |
| 07/26/2007 | WO2007082547A1 Eye tuberculosis treating agent and method for the production and use thereof |
| 07/26/2007 | WO2007082483A1 Medicament for treatment of tumor and the use thereof |
| 07/26/2007 | WO2007082482A1 Novel compound for treatment of tumor |
| 07/26/2007 | WO2007066018A3 Novel peptides and the biological use thereof |
| 07/26/2007 | WO2007062852A3 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |
| 07/26/2007 | WO2007058634B1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/26/2007 | WO2007051836A3 Compositions for treating dermatological and neurological disorders |
| 07/26/2007 | WO2007048026A3 Cgrp peptide antagonists and conjugates |
| 07/26/2007 | WO2007046781A8 Furin inhibitors |
| 07/26/2007 | WO2007046087A3 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions |
| 07/26/2007 | WO2007041487A3 Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family |
| 07/26/2007 | WO2007028110A3 Methods for using and identifying modulators of delta-like 4 |
| 07/26/2007 | WO2007022287A3 Modified vegf and pdgf with improved angiogenic properties |
| 07/26/2007 | WO2007017284A3 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |